Antifungal prophylaxis in lung transplant recipients: A systematic review and meta-analysis

Kelly M. Pennington, Misbah Baqir, Patricia J. Erwin, Raymund R Razonable, Mohammad Hassan Murad, Cassie C. Kennedy

Research output: Contribution to journalArticle

Abstract

Background: No consensus exists regarding optimal strategy for antifungal prophylaxis following lung transplant. Objective: To review data regarding antifungal prophylaxis on the development of fungal infections. Study selection/Appraisal: We searched MEDLINE, Embase, and Scopus for eligible articles through December 10, 2019. Observational or controlled trials published after January 1, 2001, that pertained to the prevention of fungal infections in adult lung recipients were reviewed independently by two reviewers for inclusion. Methods: Of 1702 articles screened, 24 were included. Data were pooled using random effects model to evaluate for the primary outcome of fungal infection. Studies were stratified by prophylactic strategy, medication, and duration (short term < 6 months and long term ≥ 6 months). Results: We found no difference in the odds of fungal infection with universal prophylaxis (49/101) compared to no prophylaxis (36/93) (OR 0.76, CI: 0.03-17.98; I2 = 93%) and preemptive therapy (25/195) compared to universal prophylaxis (35/222) (OR 0.91, CI: 0.06-13.80; I2 = 93%). The cumulative incidence of fungal infections within 12 months was not different with nebulized amphotericin (0.08, CI: 0.04-0.13; I2 = 87%) compared to systemic triazoles (0.07, CI: 0.03-0.11; I2 = 21%) (P =.65). Likewise, duration of prophylaxis did not impact the incidence of fungal infections (short term: 0.11, CI: 0.05-0.17; I2 = 89%; long term: 0.06, CI: 0.03-0.08; I2 = 51%; P =.39). Conclusions: We have insufficient evidence to support or exclude a benefit of antifungal prophylaxis.

Original languageEnglish (US)
Article numbere13333
JournalTransplant Infectious Disease
Volume22
Issue number4
DOIs
StatePublished - Aug 1 2020

Keywords

  • aspergillus
  • fungal infection
  • lung transplant
  • prophylaxis

ASJC Scopus subject areas

  • Infectious Diseases
  • Transplantation

Fingerprint Dive into the research topics of 'Antifungal prophylaxis in lung transplant recipients: A systematic review and meta-analysis'. Together they form a unique fingerprint.

  • Cite this